Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,020 DKK | +0.06% | -3.59% | -23.32% |
03-27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-23.32% | 5.23M | |
+10.29% | 115B | |
+12.28% | 106B | |
-5.84% | 24.69B | |
-1.19% | 21.97B | |
-4.78% | 19.27B | |
-11.50% | 17.56B | |
-39.36% | 17.32B | |
+5.81% | 14.03B | |
+33.13% | 12.13B |
- Stock Market
- Equities
- ORPHA Stock
- News Orphazyme A/S
- Orphazyme A/S : European ADRs Move Higher in Thursday Trading